Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Numinus Wellness Focused on Boosting Profitability and Expanding Community Support (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Cronos Group Inc CRON


Primary Symbol: T.CRON

Healthcare Cannabis
Cronos Group Inc. is a Canada-based global cannabinoid company engaged in building intellectual property by advancing cannabis research, technology and product development. The Company’s segments include United States and Rest of World. The United States operating segment consists of the manufacture and distribution of hemp-derived CBD infused products. The Rest of World operating segment is... see more

Recent & Breaking News (TSX:CRON)

Cronos Group Inc. to Hold 2023 Second Quarter Earnings Conference Call on August 8, 2023

GlobeNewswire July 20, 2023

Cronos Group Inc. confirms receipt of unsolicited indications of interest

GlobeNewswire July 6, 2023

Cronos Group Inc. Announces Results of 2023 Annual Meeting of Shareholders

GlobeNewswire June 23, 2023

Cronos Group Announces Streamlined Operating Structure to Improve Cash Flow

GlobeNewswire May 31, 2023

Cronos Group Inc. to Speak at Bernstein's 39th Annual Strategic Decisions Conference

GlobeNewswire May 30, 2023

Cronos Group Inc. to Speak at the Canaccord Genuity 7th Annual Global Cannabis Conference

GlobeNewswire May 12, 2023

Cronos Group Reports 2023 First Quarter Results

GlobeNewswire May 9, 2023

Cronos Group Inc. to Hold Virtual 2023 Annual Meeting of Shareholders

GlobeNewswire April 28, 2023

Cronos Group Inc. to Hold 2023 First Quarter Earnings Conference Call on May 9, 2023

GlobeNewswire April 25, 2023

Cronos Group Releases Cannabinoid Life Cycle Study Highlighting its Sustainable Fermentation Practices

GlobeNewswire April 21, 2023

Cronos Bolsters its Spinach® Infused Pre-roll Portfolio with CBG, CBC and CBN

GlobeNewswire April 12, 2023

S&P Dow Jones Indices Announces Changes to the S&P/TSX Composite Index

Canada NewsWire March 3, 2023

Cronos Group Reports 2022 Fourth Quarter and Full-Year Results

GlobeNewswire February 28, 2023

Cronos Group Inc. to Hold 2022 Fourth Quarter and Full-Year Earnings Conference Call on February 28, 2023

GlobeNewswire February 14, 2023

Spinach® Becomes the Number One Edible Brand in January¹

GlobeNewswire February 8, 2023

Cronos Group Inc. Announces Receipt of Notice of Relinquishment of Warrant by Altria

GlobeNewswire December 19, 2022

Cronos (TSX:CRON) unveils new CBC product

Shoran Devi December 7, 2022

Cronos Unveils its New CBC Product: Spinach FEELZ(TM) Day Trip Gummies With THC+CBC

GlobeNewswire December 7, 2022

Cronos Group Inc. to Speak at Stifel Canada's 3rd Annual Future of Healthcare Conference

GlobeNewswire November 29, 2022

Cronos Group Appoints James Holm as Chief Financial Officer

GlobeNewswire November 14, 2022